Home › Non-Small Cell Lung Cancer › Utah › West Valley City
Non-Small Cell Lung Cancer clinical trials in West Valley City, UT
25 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around West Valley City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- START - Mountain Region, West Valley City
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RecruitingPhase 1
- ALX Center 4, West Valley City
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RecruitingPhase 1/2
- START Mountain Region, West Valley City
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
RecruitingPhase 1/2
- START Mountain Region, West Valley City
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RecruitingPhase 1
- START Mountain Region, West Valley City
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RecruitingPhase 1/2
- START Mountain Region, West Valley City
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- START Mountain Region, West Valley City
A Study of MGC026 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- START Mountain Region, West Valley City
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RecruitingPhase 1
- South Texas Accelerated Research Therapeutics Mountain Region, West Valley City
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
A Study of LY4175408 in Participants With Advanced Cancer
RecruitingPhase 1
- START Mountain Region, West Valley City
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RecruitingPhase 1
- Start Mountain Region /ID# 276270, West Valley City
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RecruitingPhase 1
- START Mountain Region, LLC, West Valley City
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
RecruitingPhase 1
- START Mountain Region, LLC, West Valley City
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
RecruitingPhase 1
- START Mountain Region, West Valley City
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
RecruitingPhase 1/2
- START Mountain Region, West Valley City
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RecruitingPhase 1/2
- START Mountain Region, West Valley City
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- START Mountain Region, West Valley City
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RecruitingPhase 1/2
- START, Mountain Region, West Valley City
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in West Valley City
- Colorectal Cancer17 studies
- Breast Cancer13 studies
- Triple-Negative Breast Cancer13 studies
- Metastatic Cancer13 studies
- Pancreatic Cancer12 studies
- Cancer (all types)11 studies
- Ovarian Cancer11 studies
- Head and Neck Squamous Cell Carcinoma11 studies
- Endometrial Cancer10 studies
- Stomach Cancer8 studies
- Esophageal Squamous Cell Carcinoma7 studies
- Small Cell Lung Cancer7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.